Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

27 Mar 2026 10:00

RNS Number : 4431Y
Computacenter PLC
27 March 2026
 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and Persons Closely Associated ('PCA') with the Directors and PDMRs.

 

Vesting of Award and Subsequent Sale of Shares - Deferred Bonus Plan

 

Computacenter 2017 Deferred Bonus Plan

The Company announces that on 26 March 2026, the following conditional awards over Ordinary Shares vested for the Director below. This followed, in accordance with the rules of the Computacenter 2017 Deferred Bonus Plan, the Company vesting tranches of the related conditional 2023 Bonus Award and 2024 Bonus Award, which were granted on 26 March 2024 and 24 March 2025 respectively, over Ordinary Shares. Vesting of the tranche of the 2023 Bonus Award was subject to the completion of a two-year holding period and vesting of the tranche of the 2024 Bonus Award was subject to the completion of a one-year holding period. Further, certain of the Ordinary Shares, resulting from the vesting of the awards, were sold for 2813.08 pence each.

 

DIRECTOR

Number of shares acquired following vesting1

Number of shares sold

Number of shares retained

Mr M J Norris (Director)

9,733

9,733

-

1 On 26 March 2026, the Director listed above became entitled to ordinary shares of 75/9 pence each in the capital of the Company, as a result of Awards vesting under the DBP. Awards granted under the DBP Plan vest in two tranches with one-half of the deferred shares from the Bonus Award vesting after one year and the remaining deferred shares from the Bonus Award vesting after two years. The shares vesting above relate to the second tranche of the 2023 Bonus Award made on 26 March 2024 and the first tranche of the 2024 Bonus Award made on 24 March 2025. The shares were released to the Director on 26 March 2026 when the transaction noted above took place. The vesting amount included 459 shares, awarded as dividend equivalent shares equal in value to dividends that would have been paid on the shares in respect of which the awards vest in respect of dividend record dates during the period between the grant date and the vesting date.

 

The relevant FCA notifications are set out below.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Details of Director/Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Michael John Norris

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Executive Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following the vesting of a conditional award, made on 26 March 2024, under the Computacenter 2017 Deferred Bonus Plan (the '2023 Bonus Award'). There is no price payable on the grant or exercise of the 2023 Bonus Award. Vesting of this tranche of the 2023 Bonus Award was subject to the completion of a two year holding period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

7,267

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

7,267

 

4(e)

 

 

Date of the transaction

 

 

26-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following the vesting of a conditional award, made on 24 March 2025, under the Computacenter 2017 Deferred Bonus Plan (the '2024 Bonus Award'). There is no price payable on the grant or exercise of the 2024 Bonus Award. Vesting of this tranche of the 2024 Bonus Award was subject to the completion of a one year holding period. The remainder of the 2024 Bonus Award will vest at the completion of a second year of holding.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

2,007

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

2,007

 

4(e)

 

 

Date of the transaction

 

 

26-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired as dividend equivalents related to the grant and vesting of conditional awards, made on 26 March 2024 and 24 March 2025, under the Computacenter 2017 Deferred Bonus Plan (the 'Bonus Award Dividend Equivalents'). There is no price payable on the acquisition of the Bonus Award Dividend Equivalents.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

459

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

459

 

4(e)

 

 

Date of the transaction

 

 

26-03-2026

 

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue. 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Sale of Ordinary Shares. Sold all 9,733 Shares from the conditional awards vested, and dividend equivalent shares acquired, under the Computacenter 2017 Deferred Bonus Plan.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

28.1308

 

9,733

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

28.1308

 

 

 

9,733

 

4(e)

 

 

Date of the transaction

 

 

26-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

XLON

 

 

 

Enquiries:

 

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANDXAFKKEEA
Date   Source Headline
30th Mar 20153:00 pmRNSHolding(s) in Company
30th Mar 20152:45 pmRNSDirector/PDMR Shareholding
27th Mar 201512:54 pmRNSDirector/PDMR Shareholding
27th Mar 201512:29 pmRNSDirector/PDMR Shareholding
26th Mar 20153:23 pmRNSDirector/PDMR Shareholding
18th Mar 20153:45 pmRNSDirector/PDMR Shareholding
18th Mar 20152:00 pmRNSDirectorate Change
16th Mar 20152:45 pmRNSDirector/PDMR Shareholding
12th Mar 20157:00 amRNS2014 Final Results
24th Feb 20158:20 amRNSPurchase Offer Result and B Share Dividend
23rd Feb 20158:00 amRNSReturn of Value - Purchase Offer for B Shares
19th Feb 20153:38 pmRNSReturn of Value and Results of EGM
6th Feb 20154:55 pmRNSBlocklisting Interim Review
3rd Feb 20155:00 pmRNSPosting of Circular and Notice of General Meeting
2nd Feb 20154:46 pmRNSDisposal and Proposed Return of Value
21st Jan 20157:00 amRNSPre-Close Trading Statement
17th Dec 201412:00 pmRNSDirectorate Change
10th Dec 201410:37 amRNSSharesave Exercise
24th Nov 20141:23 pmRNSDirector/PDMR Shareholding
11th Nov 20149:21 amRNSHolding(s) in Company
27th Oct 201412:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20147:00 amRNSInterim Management Statement
8th Oct 20144:05 pmRNSHolding(s) in Company
8th Oct 20144:00 pmRNSDirector/PDMR Shareholding
19th Sep 20142:00 pmRNSHolding(s) in Company
4th Sep 201411:08 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSHalf Yearly Report
28th Jul 20142:30 pmRNSProposed Change of Auditor
24th Jul 20144:25 pmRNSReport on Cyber Crime
17th Jul 20147:00 amRNSHalf Year Pre-Close Update
30th Jun 20141:14 pmRNSTotal Voting Rights
30th May 20149:00 amRNSTotal Voting Rights
15th May 201412:05 pmRNSResult of AGM
14th May 20142:35 pmRNSHolding(s) in Company
14th May 20142:30 pmRNSDirector/PDMR Shareholding
30th Apr 20142:33 pmRNSTotal Voting Rights
24th Apr 20147:00 amRNSInterim Management Statement
8th Apr 20144:29 pmRNSNotice of AGM
31st Mar 20143:30 pmRNSTotal Voting Rights
28th Mar 201412:15 pmRNSDirector/PDMR Shareholding
20th Mar 20143:00 pmRNSBlocklisting Interim Review
20th Mar 20142:30 pmRNSDirector/PDMR Shareholding
14th Mar 20142:40 pmRNSHolding(s) in Company
14th Mar 20141:15 pmRNSDirector/PDMR Shareholding
12th Mar 20144:05 pmRNSDirectorate Change - Holding Announcement
11th Mar 20147:00 amRNSFinal Results 2013
28th Feb 201412:06 pmRNSTotal Voting Rights
28th Feb 201412:06 pmRNSDirector Declaration
31st Jan 201411:00 amRNSTotal Voting Rights
16th Jan 20147:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.